IPO registrations (S-1, F-1) · Registrants
Sequoia Vaccines, Inc.
- SEC CIK
- 1650789 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2023-11-06, last 2024-06-18; 1 initial registration, 5 amendments
- Outcome
- Withdrawal requested 2025-05-05
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 1912 INNERBELT BUSINESS CENTER DR, St. Louis, MO 63114
- EIN
- 46-0813244
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $8.00–$10.00 per share (S-1/A filed 2024-06-18)
- Shares offered
- 2,775,000
- Listing
- NYSE American under the symbol SQVI
- Lead underwriters
- ING; ThinkEquity
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: SEQUOIA VACCINES EXACT (EIN (EXACT))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2023-11-06 | S-1 | S-1 (registration) | Sequoia Vaccines, Inc. | 0001213900-23-083938 ↗ |
| 2023-11-29 | S-1/A | S-1/A (amendment) | Sequoia Vaccines, Inc. | 0001213900-23-091115 ↗ |
| 2024-01-26 | S-1/A | S-1/A (amendment) | Sequoia Vaccines, Inc. | 0001213900-24-006963 ↗ |
| 2024-02-20 | S-1/A | S-1/A (amendment) | Sequoia Vaccines, Inc. | 0001213900-24-015411 ↗ |
| 2024-02-29 | S-1/A | S-1/A (amendment) | Sequoia Vaccines, Inc. | 0001213900-24-018577 ↗ |
| 2024-06-18 | S-1/A | S-1/A (amendment) | Sequoia Vaccines, Inc. | 0001213900-24-053872 ↗ |
| 2025-05-05 | RW | RW (withdrawal request) | Sequoia Vaccines, Inc. | 0001213900-25-039537 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-18 | S-1/A | registration statement | $8.00–$10.00 | 2,775,000 | - | NYSE American SQVI | 2 | primary document; range, shares headline, cover names 1 | document ↗ |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | SEQUOIA VACCINES | MO | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Patent assignee | Sequoia Vaccines, Inc. | MO | Patents (USPTO) | name and state |
| Form 5500 plan sponsor | SEQUOIA VACCINES | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), MO first:
- AVAX TECHNOLOGIES INC MO
- BioNTech SE 2M
- Immatics N.V. 2M
- CHEMOKINE THERAPEUTICS CORP A1
- Fusion Pharmaceuticals Inc. A6
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ
- GENETIC TECHNOLOGIES LTD C3
- MESOBLAST LTD C3
- Ablynx NV C9
- SANGAMO THERAPEUTICS, INC CA
In other datasets, the same topic (Health) in MO:
- Nonprofit: 49 XXXXY FUND (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health